A carregar...
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Cancer immunotherapy, which reactivates weakened immune cells of cancer patients, has yielded great success in recent years. Among immunotherapeutic agents, immune checkpoint inhibitors have been of particular interest and have gained approval by the FDA for treatment of cancers. Immune checkpoint b...
Na minha lista:
| Publicado no: | J Immunol Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7925068/ https://ncbi.nlm.nih.gov/pubmed/33681388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6661406 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|